JANSSEN-CILAG INTERNATIONAL N.V.
ItalyAll medications by this manufacturer
-
Akeega
Form: tablets, film-coated
Active substance Dosage NIRAPARIB — ABIRATERONE — ATC: L01XK
-
Balversa
Form: tablets, film-coated
Active substance Dosage ERDAFITINIB — ATC: L01EN01
-
Byannli
Form: suspension for injection, prolonged release
Active substance Dosage PALIPERIDONE — ATC: N05AX13
-
Caripul
Form: solution for infusion, powder for preparation
Active substance Dosage Sodium Epoprostenol — ATC: B01AC09
-
Carvykti
Form: solution for infusion
Active substance Dosage CILTACABTAGENE AUTOLEUCEL — ATC: L01XL05
-
Dacogen
Form: solution for infusion, powder for preparation
Active substance Dosage DECITABINE — ATC: L01BC08
-
Darzalex
Form: solution for infusion, concentrate
Active substance Dosage DARATUMUMAB — ATC: L01FC01
-
Edurant
Form: tablets, film-coated
Active substance Dosage Rilpivirine — ATC: J05AG05
-
Erleada
Form: tablets, film-coated
Active substance Dosage APALUTAMIDE — ATC: L02BB05
-
Imaavy
Form: solution for infusion, concentrate
Active substance Dosage NIPOCALIMAB — ATC: L04AL03
-
Imbruvica
Form: capsules, hard gelatin
Active substance Dosage IBRUTINIB — ATC: L01EL01
-
Intelence
Form: tablets
Active substance Dosage ETRAVIRINE — ATC: J05AG04
-
Invega
Form: tablets, prolonged-release
Active substance Dosage PALIPERIDONE — ATC: N05AX13
-
Invokana
Form: tablets, film-coated
Active substance Dosage CANAGLIFLOZIN — ATC: A10BK02
-
Lazcluze
Form: tablets, film-coated
Active substance Dosage LAZERTINIB — ATC: L01EB09
-
Olympus
Form: tablets, film-coated
Active substance Dosage MACITENTAN — ATC: C02KX04
-
Prezista
Form: tablets, film-coated
Active substance Dosage DARUNAVIR ETHANOLATE — ATC: J05AE10
-
Rekambys
Form: suspension for injection, prolonged release
Active substance Dosage Rilpivirine — ATC: J05AG05
-
Remicade
Form: powder for concentrate for infusion solution
Active substance Dosage INFLIXIMAB — ATC: L04AB02
-
Rezolsta
Form: tablets, film-coated
Active substance Dosage DARUNAVIR ETHANOLATE — COBICISTAT — ATC: J05AR14
-
Rybrevant
Form: solution for infusion, concentrate
Active substance Dosage AMIVANTAMAB — ATC: L01FX18
-
Simpóni
Form: solution for injection, in pre-filled pen
Active substance Dosage GOLIMUMAB — ATC: L04AB06
-
Sirturo
Form: tablets
Active substance Dosage BEDAQUILINE — ATC: J04AK05
-
Spravato
Form: spray, nasal solution
Active substance Dosage ESKETAMINE — ATC: N06AX27
-
Stelara
Form: solution for injection
Active substance Dosage USTEKINUMAB — ATC: L04AC05
-
Symtuza
Form: tablets, film-coated
Active substance Dosage DARUNAVIR — EMTRICITABINE — COBICISTAT — TENOFOVIR ALAFENAMIDE — ATC: J05AR22
-
Talvey
Form: solution for injection
Active substance Dosage TALQUETAMAB — ATC: L01FX
-
Tecvayli
Form: solution for injection
Active substance Dosage TECLISTAMAB — ATC: L01FX24
-
Tracleer
Form: tablets, film-coated
Active substance Dosage Bosentan Monohydrate — ATC: C02KX01
-
Tremfya
Form: solution for injection, pre-filled syringe
Active substance Dosage GUSELKUMAB — ATC: L04AC16
-
Trevicta
Form: suspension for injection, prolonged release
Active substance Dosage PALIPERIDONE PALMITATE — ATC: N05AX13
-
Uptravi
Form: tablets, film-coated
Active substance Dosage SELEXIPAG — ATC: B01AC27
-
Velcade
Form: solution for injection
Active substance Dosage BORTEZOMIB — ATC: L01XG01
-
Vokanamet
Form: tablets, film-coated
Active substance Dosage METFORMIN — CANAGLIFLOZIN — ATC: A10BD16
-
Xeplion
Form: suspension for injection, prolonged release
Active substance Dosage PALIPERIDONE PALMITATE — ATC: N05AX13
-
Yuvanci
Form: tablets, film-coated
Active substance Dosage MACITENTAN — TADALAFIL — ATC: C02KX54
-
Zavesca
Form: capsules, hard gelatin
Active substance Dosage MIGLUSTAT — ATC: A16AX06
-
Zytiga
Form: tablets
Active substance Dosage ABIRATERONE ACETATE — ATC: L02BX03